Boys and young men after vaccination against COVID-19 faced myocarditis and pericarditis.
The US Centers for Disease Control and Prevention (CDC) is sounding the alarm and calling for urgent action in connection with hundreds of cases of heart inflammation in teenage boys who received Pfizer and Moderna vaccines from COVID-19. According to the CDC, a total of 226 cases of myocarditis and pericarditis have been reported.
The heads of the US Centers for Disease Control called an emergency meeting due to higher than previously thought cases of heart inflammation among young people who were given the COVID-19 vaccines by Pfizer and Moderna.
According to the Daily Mail, CDC experts will meet on June 18 to discuss 226 possible cases of heart inflammation, mostly in adolescent boys and young adults who have been given the Pfizer or Moderna COVID-19 vaccine.
According to the CDC, the number of cases was higher than expected. Experts announced that they are investigating the problem in adolescents and young men after receiving a second dose of the coronavirus vaccine.
According to the agency, a total of 226 cases have been reported that may meet the “working case definition” of the Centers for Disease Control for Myocarditis and Pericarditis after vaccinations.
Myocarditis is an inflammation of the heart muscle, and pericarditis is an inflammation of the outer lining of the heart. These types of heart inflammation can be caused by a variety of infections, including the COVID-19 outbreak, as well as certain medications.
Of the 226 young people who have experienced heart problems, three are in the intensive care unit, 15 are hospitalized, and 41 have ongoing symptoms. The rest (167 people) have already recovered.
It is unclear whether the condition is caused by vaccinations, but it is believed that reports of cases of this disease are extremely rare. The Centers for Disease Control continues to urge all Americans aged 12 and older to get vaccinated against the coronavirus.
More than 130 million Americans have received both the first and second doses of Pfizer and Moderna vaccines. This means that only 0.000173846 percent of people who were given the second dose reported a side effect associated with heart inflammation.
Cases are reported through the US Vaccine Adverse Event Reporting System (VAERS). The system accepts reports from everyone, regardless of the probability of whether this symptom is caused by the vaccine or not.
In total, the VAERS system received 573 reports of myocarditis and pericarditis after the patient received the second dose of the vaccine. Of this total, 372 reports were received from people who had received the Pfizer vaccine, and the remaining 201 from the Moderna vaccine.
According to the CDC, more than half of the cases reported after people received a second dose of the vaccine were in people between the ages of 12 and 24. This group accounts for less than 9 percent of the administered doses. Almost two-fifths of the cases were found in males. The vast majority of cases occurred within a week of vaccination. Symptoms included chest pain and difficulty breathing.
Experts say that the CDC’s results are mostly “consistent” with the findings of the Israeli Ministry of Health, which was the first to report a likely link between the Pfizer vaccine and the disease in young men.
According to the Daily Mail, doctors were first warned of a possible link between myocarditis and vaccines back in May amid reports of cases of the disease among young men. The Centers for Disease Control has urged health care providers to ask patients with symptoms of heart inflammation if they have taken the COVID-19 vaccine.